---
title: "Bill.com Non-GAAP EPS of $0.84 beats by $0.13, revenue of $436.2M beats by $5.67M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296396566.md"
description: "Bill.com reported Q1 FY26 Non-GAAP EPS of $0.84, beating estimates by $0.13, with revenue of $436.2M surpassing forecasts by $5.67M. The company provided Q1 FY27 guidance projecting total revenue between $432.5M-$442.5M and full-year FY27 revenue between $1.807B-$1.857B. Full-year non-GAAP net income per diluted share is guided at $3.56-$3.79, significantly above the consensus of $3.38."
datetime: "2026-08-19T20:21:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296396566.md)
  - [en](https://longbridge.com/en/news/296396566.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296396566.md)
generator: "portal-rs"
---

# Bill.com Non-GAAP EPS of $0.84 beats by $0.13, revenue of $436.2M beats by $5.67M


### Related Stocks

- [BILL.US](https://longbridge.com/en/quote/BILL.US.md)

## Related News & Research

- [BILL (NYSE:BILL) Posts Quarterly Earnings Results, Beats Estimates By $0.13 EPS](https://longbridge.com/en/news/296396999.md)
- [BILL Reports Fourth Quarter and Fiscal Year 2026 Financial Results | BILL Stock News](https://longbridge.com/en/news/296394637.md)
- [BrainStorm Cell Therapeutics GAAP EPS of -$0.35](https://longbridge.com/en/news/296069988.md)
- [These Analysts Revise Their Forecasts On Bill Holdings After Q4 Earnings](https://longbridge.com/en/news/296522404.md)
- [Nuvve GAAP EPS of -$14.45, revenue of $1.23M](https://longbridge.com/en/news/296071033.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**